NovaBay Pharmaceuticals to Hold 2021 Fourth Quarter and Full Year Conference Call on March 29
March 22 2022 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
that it will report financial results for the three and 12 months
ended December 31, 2021 after market close on Tuesday, March 29,
2022 and will hold an investment community conference call that day
beginning at 4:30 p.m. Eastern time.
Date/Time:
Tuesday, March 29, 4:30 p.m. ET / 1:30
p.m. PT
Pre-Registration:
Participants can pre-register for the
conference call here:
Callers who pre-register will be given a
conference passcode and unique PIN to gain immediate access to the
call and bypass the live operator. Participants may pre-register at
any time, including up to and after the call start time.
Dial In:
Those who choose not to pre-register can
access the live conference call by dialing the following and
requesting the NovaBay Pharmaceuticals call:
866-777-2509 from within the U.S.
412-317-5413 from outside the U.S.
The live webcast of the conference call also will be available
at http://novabay.com/investors/events. A replay of the call will
be available beginning two hours after its completion through April
19, 2022 by dialing 877-344-7529 from within the U.S., 855-669-9658
from Canada or 412-317-0088 from outside the U.S., and entering
conference ID 1992038. The webcast will also be archived at
http://novabay.com/investors/events.
About NovaBay Pharmaceuticals, Inc: NovaBay
Pharmaceuticals, Inc. is a pharmaceutical company that develops and
sells scientifically created and clinically proven consumer
products for the eyecare and skincare markets. Avenova® is the most
prescribed antimicrobial lid and lash spray in the eyecare market.
In November 2021, NovaBay acquired DERMAdoctor, LLC, a company
offering more than 30 dermatologist-developed skincare products
sold through traditional domestic retailers, digital beauty
channels and international distributors.
Socialize and Stay Informed on
NovaBay’s Progress
Like us on Facebook Follow us on Twitter Connect with NovaBay on
LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220317005008/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2024 to May 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From May 2023 to May 2024